Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis

Journal of Medical Imaging and Radiation Oncology

Volumn 54, Issue 4, 2010, Pages 358-364

  Mir, N ^a   Sohaib, S A ^a   Collins, D ^a   Koh, D M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

diffusion MR; fusion imaging; lymph node

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSENSUS; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; INGUINAL LYMPH NODE; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE; PELVIS CANCER; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RADIOLOGIST; RECTUM; SACRUM; TREATMENT PLANNING; VISIBILITY;

ADULT; AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; PELVIC NEOPLASMS; PELVIS; RETROSPECTIVE STUDIES;

EID: 77955837629     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2010.02182.x     Document Type: Article

References (25)

1. Koh DM, Hughes M, Husband JE. Cross-sectional imaging of nodal metastases in the abdomen and pelvis. Abdom Imaging 2006 31 : 632 43.
2. Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging. J Nucl Med 2004 45 : 1509 18.
3. Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991 180 : 319 22.
4. Lien HH, Stenwig AE, Ous S, Fossa SD. Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumor. Acta Radiol Diagn (Stockh) 1986 27 : 199 203.
5. Genereux GP, Howie JL. Normal mediastinal lymph node size and number: CT and anatomic study. AJR 1984 142 : 1095 100.
6. Vilarino-Varela MJ, Taylor A, Rockall AG, Reznek RH, Powell ME. A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging. Radiother Oncol 2008 89 : 192 6.
7. Shih HA, Harisinghani M, Zietman AL, Wolfgang JA, Saksena M, Weissleder R. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys 2005 63 : 1262 9.
8. Levenback C, Coleman RL, Burke TW et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002 20 : 688 93.
9. Heesakkers RA, Jager GJ, Hovels AM et al. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology 2009 251 : 408 14.
10. Dinniwell R, Chan P, Czarnota G et al. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009 74 : 844 51.
11. Taylor A, Rockall AG, Powell ME. An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. Clin Oncol (R Coll Radiol) 2007 19 : 542 50.
12. Taylor A, Rockall AG, Reznek RH, Powell ME. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005 63 : 1604 12.
13. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 2007 188 : 1622 35.
14. Ridit analysis. N Engl J Med 1968 279 : 1453 4.
15. Bullimore D. RIDIT analysis for qualitative and subjective clinical data. Aliment Pharmacol Ther 1988 2 : 43 5.
16. Donaldson GW. Ridit scores for analysis and interpretation of ordinal pain data. Eur J Pain 1998 2 : 221 7.
17. Thurairaja R, Studer UE, Burkhard FC. Indications, extent, and benefits of pelvic lymph node dissection for patients with bladder and prostate cancer. Oncologist 2009 14 : 40 51.
18. Grubnic S, Vinnicombe SJ, Norman AR, Husband JE. MR evaluation of normal retroperitoneal and pelvic lymph nodes. Clin Radiol 2002 57 : 193 200 discussion 201-4.
19. Klerkx WM, Heintz AP, Mali WP et al. Lymph node detection by MRI before and after a systematic pelvic lymphadenectomy. Gynecol Oncol 2009 114 : 315 18.
20. McCauley TR, Rifkin MD, Ledet CA. Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagnetic iron oxide contrast. J Magn Reson Imaging 2002 15 : 492 7.
21. Will O, Purkayastha S, Chan C et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 2006 7 : 52 60.
22. Vandecaveye V, De Keyzer F, Vander Poorten V et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009 251 : 134 46.
23. Lin G, Ho KC, Wang JJ et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 2008 28 : 128 35.
24. Kwee TC, Takahara T, Luijten PR, Nievelstein RA. ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 2009 (Apr 15). [Epub ahead of print HC, Triantafyllou M, Birkhaeuser FD et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009 55 : 761 9
25. Lin G, Ng KK, Chang CJ et al. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging-initial experience. Radiology 2009 250 : 784 92.